A very unusual and surprising property of protein-coding genes is that if a codon A appears with a certain frequency in genes, the reverse-complement codon of A will also have a similar frequency of occurrence. For example: If CTT (leucine) appears at a frequency of 1%, the reverse complement codon AAG (lysine) will also appear at roughly 1%. If CGT (arginine) appears at 0.2%, ACG (threonine) will appear at around 0.2%. (These are whole-genome frequencies.)
This correlation is strongest (r=0.75) for organisms with a high genomic G+C content, such as Streptomyces griseus, and lowest (r=0.28) in low-GC organisms like Clostridium botulinum.
This is a very peculiar property, when you think about it. We don't usually imagine an organism being constrained in its choice of codons for a particular protein. If a particular protein calls for a huge amount of leucines (CTTCTTCTT) we don't imagine that there's a requirement for an equivalent quantity of AAG to be used somewhere else. And yet, the correlation between frequency-of-occurrence of a codon and its antisymmetric twin is, as I say, surprisingly high in many organisms.
This sort of thing is very hard to explain without invoking a theory of proteogenesis that involves antisense proteins. Imagine a poly-lysine gene of AAA repeated 100 times. The gene gets duplicated on the opposite strand. Now the original strand has 100 AAAs and a run of 100 TTTs. If a reading frame opens up on the TTT stretch (and the protein is beneficial to the organism; it survives), there is now codon/anticodon parity of the kind I'm describing, between codons in the poly-lysine gene and the poly-phenylalanine (TTT) gene.
Why does this relationship hold for high-GC organisms but not as much for low-GC organisms? Probably because antisense genes in high-AT organisms contain a lot of stop codons (TAA, TGA, TAG, which by the way occur at about the same frequencies as TTA, TCA, and CTA, respectively). The presence of few stop codons in high-GC antisense genes gives those genes a chance to be expressed and evolve further. Of course, if you buy this theory, it tends to argue for a "GC World" scenario in which the early proteosome evolved from GC-rich double-stranded genomes.
To illustrate the unusual correlation I'm talking about, I took the codon frequencies of Pseudomonas fluorescens PF01 (genome-wide) and made a graph that plots the frequency of occurrence of each codon on the x-axis, versus the frequency of occurrence of the corresponding reverse-complement codon on the y-axis. (So if CTA occurs at 0.3% and TAG occurs at 0.2%, I plot a point at [0.3, 0.2].) The SVG graph (below) is interactive: You should be able to hover over a point and see a tooltip that shows the identity of the corresponding codon, and its reverse twin, and their respective frequencies.
NOTE: If your browser does not support SVG, a PNG copy of the graph is here.
The symmetry pattern is expected: For every codon/anticodon there's a corresponding anticodon/codon pair with frequencies swapped. What's more important than the symmetry pattern is the fact that frequency values in Y increase monotonically in X and vice versa, with a correlation coefficient in this case of r=0.63 (F-statistic 41, p < .001). This means that codons tend to occur at about the same frequencies as their reverse complement codons. There are outliers, to be sure, but the overall trend is statistically solid.
Leave a comment if you have any thoughts on what's going on here.
Showing posts with label codon. Show all posts
Showing posts with label codon. Show all posts
Saturday, April 19, 2014
Sunday, April 13, 2014
Whooping Cough Genomics
Pertussis, also known as whooping cough, is a highly contagious respiratory infection caused by Bordetella pertussis, a small aerobic bacterium that secretes numerous toxins capable of disrupting a normal immune response. The disease is rarely fatal but leaves victims with a nasty cough that can last weeks. In 2012, in the U.S., some 48,277 cases of pertussis were reported to the CDC. Of those cases, only 20 were fatal. By contrast, 28 Americans were killed by lightning the same year.
Unlike tuberculosis (which has been with us for 3 million years), Bordetella shows evidence of being a fairly new (and still rapidly evolving) pathogen, although in this case "fairly new" could still mean 700,000 years.
The complete DNA sequence of B. pertussis has been available for several years. It shows a moderate-size genome (of 4 million base pairs) encoding 3,447 genes, with a substantial number (360) of pseudogenes. The latter represent genes that have (by one means or another) been inactivated, whether through the appearance of premature stop codons in the gene, loss of a promoter region, random deletions, or what have you.
What makes Bordetella's pseudogenes interesting is that they're in remarkably good shape, as pseudogenes go. Usually, once a gene gets inactivated (goes pseudo), it begins to accumulate random point mutations, deletions, insertions, etc. at a substantial rate. In other words it deteriorates, since (supposedly) it's no longer under selection pressure. But when Australian researchers looked at 358 pseudogenes in B. pertussis Tohama I strain, they were shocked to find that the rate of nucleotide polymorphisms (i.e., changes to individual base-pairs in the DNA) was actually lower in pseudogenes than in regular genes (4.7E-5 per site versus 5.1). That's exactly the opposite of what's expected. The researchers commented, somewhat laconically: "This suggests that most pseudogenes in B. pertussis were formed in the recent past and are yet to accumulate more mutations than functional genes."
What other explanation is there? Well, the most obvious alternative explanation is that the genes are still under selection pressure, even though they're turned off. How can that be? I can think of any number of scenarios; perhaps that'll be a future blog post. Suffice it for now to say, ribosomes are not totally unforgiving of missing stop codons (read up on tmRNA) nor are they unforgiving, in all cases, of frameshifts (read about programmed frameshifts), and if an open reading frame should appear on a pseudogene's antisense strand, you now have an RNA silencer (potentially) for the remaining good copy or copies of the gene, with attendant gene-modulation possibilities.
It's worth pointing out that pseudogenes in M. leprae (the leprosy bacterium) are not only conserved and ancient but continue to show strong homology to working orthologues in M. tuberculosis (and even more distantly related organisms such as Gordonia, Corynebacterium, and Nocardia) after millions of years. More of which, in a later post.
For now, I thought it might be worth looking at the base composition of B. pertussis pseudogenes to see if they're riddled with frameshift errors (as is the case with M. leprae's pseudogenes). When I analyzed all 1,125,521 codons for all normal (not pseudo) genes in B. pertussis Tohama I strain, the resulting "paintball diagram" of base composition came up looking like this:
Here, we're looking at purine (A+G) content versus G+C content for each base position in the codons. Every dot represents a gene's worth of data. Not unexpectedly, the most extreme G+C values occur in the third ("wobble") base. Codon base one (red dots) is purine-rich, centering on y=0.58. This is typical of most codons in most genes, in most organisms. Notice the "breakaway cloud" of gold points underneath the main gold cloud (at y<0.4). These points represent genes in which the second codon base is mostly a pyrimidine (C or T). Codons with a pyrimidine in base two tend to code for nonpolar amino acids. Thus, the breakaway cloud of gold points represents membrane-associated proteins. In this case, we're looking at about 558 genes falling in that category.
Now look at the paintball diagram for the organism's 360 pseudogenes:
In this case, there's a considerable amount of random statistical splay, but some of that is due simply to the fact that pseudogenes are a good deal shorter than normal genes, giving rise to more noise in the signal. (In this case, the average length of a pseudogene is 482 bases, vs. 982 for the 3,447 "normal" genes.) Even with considerable noise, though, it's apparent that the dot clusters tend to center on different parts of the graph, corresponding to the expected locations for normal genes. (Contrast this with the situation in M. leprae, where pseudogenes are riddled with frameshifts, rendering the concept of "codon base position" moot. Refer to the second paintball graph on this page.) Thus, we can say with some confidence that frameshifts are not so rampant in B. pertussis pseudogenes as to have rendered the concept of codons irrelevant. In fact, compared to M. leprae, pseudogenes in B. pertussis are comparatively unaffected by frameshifts. This tends to support the view of the Australian researchers (mentioned earlier) that pseudogenes in B. pertussis have not had enough time to accumulate very many mutations. But it can also be hypothesized that B. pertussis has had plenty of time (700,000 years, in fact) in which to accumulate mutations in its pseudogenes, yet has not done so. The evidence suggests that if anything, Bordetella repairs pseudogenes even more faithfully than regular genes.
At this point it might be relevant to interject that while M. leprae (like other members of the Mycobacteria) lacks the MutS/MutL mismatch repair system, Bordetella does, in fact, have a MutS/MutL mismatch repair system, and this may explain the relative paucity of frameshift errors in Bordetella pseudogenes. But it also implies (rather queerly) that Bordetella goes out of its way to repair its pseudogenes.
Interestingly, 234 out of 360 pseudogenes have a AG1 (purine, base one) content greater than 55%, which means they're probably still "in frame." Of these 234, some 69 (30%) have AG2 less than 40%, meaning they're most likely genes for membrane-associated proteins. If we look at the 2,456 normal genes that have AG1 greater than 55%, only 398 (16%) are putative membrane-associated proteins (with AG2 less than 40%). Bottom line: Pseudogenes for putative membrane-associated proteins are twice as likely to still be in-frame. While this could be a statistical fluke, it could also be that membrane proteins are somehow "spared" preferentially when it comes to leaving pseudogenes translatable. To put it differently: Pseudogenes for non-membrane-associated proteins are less likely to remain in-frame. This makes sense, in that much of Bordetella's pathogenicity can be ascribed to proteins that make up cell-surface antigens or that transport toxins to the outside world. Some of the toxic surface proteins may, in fact, be nonsense (or partial-nonsense) proteins—products of pseudogenes.
![]() |
| Bordetella pertussis |
The complete DNA sequence of B. pertussis has been available for several years. It shows a moderate-size genome (of 4 million base pairs) encoding 3,447 genes, with a substantial number (360) of pseudogenes. The latter represent genes that have (by one means or another) been inactivated, whether through the appearance of premature stop codons in the gene, loss of a promoter region, random deletions, or what have you.
What makes Bordetella's pseudogenes interesting is that they're in remarkably good shape, as pseudogenes go. Usually, once a gene gets inactivated (goes pseudo), it begins to accumulate random point mutations, deletions, insertions, etc. at a substantial rate. In other words it deteriorates, since (supposedly) it's no longer under selection pressure. But when Australian researchers looked at 358 pseudogenes in B. pertussis Tohama I strain, they were shocked to find that the rate of nucleotide polymorphisms (i.e., changes to individual base-pairs in the DNA) was actually lower in pseudogenes than in regular genes (4.7E-5 per site versus 5.1). That's exactly the opposite of what's expected. The researchers commented, somewhat laconically: "This suggests that most pseudogenes in B. pertussis were formed in the recent past and are yet to accumulate more mutations than functional genes."
What other explanation is there? Well, the most obvious alternative explanation is that the genes are still under selection pressure, even though they're turned off. How can that be? I can think of any number of scenarios; perhaps that'll be a future blog post. Suffice it for now to say, ribosomes are not totally unforgiving of missing stop codons (read up on tmRNA) nor are they unforgiving, in all cases, of frameshifts (read about programmed frameshifts), and if an open reading frame should appear on a pseudogene's antisense strand, you now have an RNA silencer (potentially) for the remaining good copy or copies of the gene, with attendant gene-modulation possibilities.
It's worth pointing out that pseudogenes in M. leprae (the leprosy bacterium) are not only conserved and ancient but continue to show strong homology to working orthologues in M. tuberculosis (and even more distantly related organisms such as Gordonia, Corynebacterium, and Nocardia) after millions of years. More of which, in a later post.
For now, I thought it might be worth looking at the base composition of B. pertussis pseudogenes to see if they're riddled with frameshift errors (as is the case with M. leprae's pseudogenes). When I analyzed all 1,125,521 codons for all normal (not pseudo) genes in B. pertussis Tohama I strain, the resulting "paintball diagram" of base composition came up looking like this:
Here, we're looking at purine (A+G) content versus G+C content for each base position in the codons. Every dot represents a gene's worth of data. Not unexpectedly, the most extreme G+C values occur in the third ("wobble") base. Codon base one (red dots) is purine-rich, centering on y=0.58. This is typical of most codons in most genes, in most organisms. Notice the "breakaway cloud" of gold points underneath the main gold cloud (at y<0.4). These points represent genes in which the second codon base is mostly a pyrimidine (C or T). Codons with a pyrimidine in base two tend to code for nonpolar amino acids. Thus, the breakaway cloud of gold points represents membrane-associated proteins. In this case, we're looking at about 558 genes falling in that category.
Now look at the paintball diagram for the organism's 360 pseudogenes:
In this case, there's a considerable amount of random statistical splay, but some of that is due simply to the fact that pseudogenes are a good deal shorter than normal genes, giving rise to more noise in the signal. (In this case, the average length of a pseudogene is 482 bases, vs. 982 for the 3,447 "normal" genes.) Even with considerable noise, though, it's apparent that the dot clusters tend to center on different parts of the graph, corresponding to the expected locations for normal genes. (Contrast this with the situation in M. leprae, where pseudogenes are riddled with frameshifts, rendering the concept of "codon base position" moot. Refer to the second paintball graph on this page.) Thus, we can say with some confidence that frameshifts are not so rampant in B. pertussis pseudogenes as to have rendered the concept of codons irrelevant. In fact, compared to M. leprae, pseudogenes in B. pertussis are comparatively unaffected by frameshifts. This tends to support the view of the Australian researchers (mentioned earlier) that pseudogenes in B. pertussis have not had enough time to accumulate very many mutations. But it can also be hypothesized that B. pertussis has had plenty of time (700,000 years, in fact) in which to accumulate mutations in its pseudogenes, yet has not done so. The evidence suggests that if anything, Bordetella repairs pseudogenes even more faithfully than regular genes.
At this point it might be relevant to interject that while M. leprae (like other members of the Mycobacteria) lacks the MutS/MutL mismatch repair system, Bordetella does, in fact, have a MutS/MutL mismatch repair system, and this may explain the relative paucity of frameshift errors in Bordetella pseudogenes. But it also implies (rather queerly) that Bordetella goes out of its way to repair its pseudogenes.
Interestingly, 234 out of 360 pseudogenes have a AG1 (purine, base one) content greater than 55%, which means they're probably still "in frame." Of these 234, some 69 (30%) have AG2 less than 40%, meaning they're most likely genes for membrane-associated proteins. If we look at the 2,456 normal genes that have AG1 greater than 55%, only 398 (16%) are putative membrane-associated proteins (with AG2 less than 40%). Bottom line: Pseudogenes for putative membrane-associated proteins are twice as likely to still be in-frame. While this could be a statistical fluke, it could also be that membrane proteins are somehow "spared" preferentially when it comes to leaving pseudogenes translatable. To put it differently: Pseudogenes for non-membrane-associated proteins are less likely to remain in-frame. This makes sense, in that much of Bordetella's pathogenicity can be ascribed to proteins that make up cell-surface antigens or that transport toxins to the outside world. Some of the toxic surface proteins may, in fact, be nonsense (or partial-nonsense) proteins—products of pseudogenes.
Sunday, May 26, 2013
Chargaff's Second Parity Rule is Violated in Proportion to Genome A+T Content
Erwin Chargaff was the first to notice, in the early 1950s, before Watson and Crick deduced the structure of DNA, that the quantity of purines in DNA equals the quantity of pyrimidines (specifically, the amount of adenine equals the amount of thymine; and the amount of guanine equals the amount of cytosine). This observation was key to establishing the structure of DNA, and it is often cited as Chargaff's first parity rule. But Chargaff also made another observation (the second parity rule), namely that even within a single strand of DNA, the amount of adenine tends to equal the amount of thymine and the amount of guanine tends to equal the amount of cytosine.
It's easy to understand why the first parity rule holds true, because complementarity of DNA strands depends on A pairing with T and G pairing with C; these pairings give rise to the "rungs" of the DNA ladder and ensure that copying of strands occurs with total fidelity during cell division. But there doesn't seem to be any a priori reason why the second parity rule should hold true. And in fact, it often doesn't hold true, as Wacław Szybalski noted in 1966 when he reported finding imbalances of purines and pyrimidines in bacteriophage and other DNA samples. Szybalski observed that in most cases, protein-coding regions of DNA tend to have slightly more purines than pyrimidines on one strand and slightly more pyrimidines than purines on the other strand, such that messenger RNA ends up purine-heavy.
If you're having trouble visualizing the situation, imagine a very short (12-base) "chromosome" containing 50% G+C content. One possibility is that one strand looks like GGGGGGTTTTTT and the other strand is CCCCCCAAAAAA. In this case half the purines (all the G's) are on one strand and half (A's) are on the other. But you could just as easily have strands be GGGGGGAAAAAA and CCCCCCTTTTTT. In this case, one strand is all-purines, the other all-pyrimidines. Both examples violate Chargaff's second rule, which requires that G = C and A = T within each strand (e.g., GGGCCCTTTAAA + CCCGGGAAATTT would obey the rule).
To my knowledge, no one has yet reported the fact (which I'll now report) that the degree to which Chargaff's second parity rule is violated depends on the G+C content of the source genome (at least for bacteria). Simply put, organisms with a G+C content of around 68% obey Chargaff's rules. Organisms with more than 68% G+C content violate Chargaff's second rule in the direction of pyrimidine loading of mRNA. Organisms with less than 68% G+C content (which of course includes the overwhelming majority of organisms) have purine-heavy DNA, to a degree that depends on the amount of A+T in the DNA.
The above graph shows how this relationship works. To create the graph, I did a statistical analysis of codon usage in 93 bacterial species. Organisms were chosen so as to obtain representatives across the AT/GC spectrum. No genus is represented more than once. In order to get as broad a sampling as possible, I included 14 intracellular symbionts with ultra-low G+C content (plus one such creature—Candidatus Hodgkinia cicadicola—with a 58% G+C content); many extremophiles; heterotrophs and autotrophs; pathogens and non-pathogens; and organisms with large and small genomes. The complete organism list is presented in a table further below.
Codon usage statistics for each organism were obtained using tools at http://genomevolution.org. Relative prevalences of A, T, G, and C in the genomes' coding regions were determined by codon frequency analysis. The purine:pyrimidine ratio was simply calculated as (A+G)/(C+T) based on the codon-wise frequency of usage of each base.
What we see is that while there is a good deal of noise in the data, nevertheless it's quite clear that purine/pyrimidine ratios increase sharply as genome G+C decreases.Organisms for which Chargaff's second rule holds true (points falling at y = 1.0) are in a small minority. Most organisms have purine-rich coding regions, resulting in purine-rich mRNA.
Purine enrichment occurs for both adenine and guanine. For example, in Clostridium botulinum (genome G+C = 28.21%), codon analysis reveals G/C/A/T relative abundances (on the coding strand) of 18.3/10.8/40.3/30.6.
Intra-codon base position analysis reveals that purine enrichment is far more concentrated in position one of the codon than other positions. The graphs below show the purine balance on a position-by-position basis, for each base in a codon.
Most of the variation in purine/pyrimidine ratio happens in position 1 of the codon (the 'A' in ATG, for example). Notice that the purine/pyrimidine ratio in this position is well above 1.0 for all organisms.
Variation in purine loading at the second position of the codon is more carefully controlled (notice that there is less "scatter" in this graph). The y-axis scale is different here than in the previous graph, hence the slope is quite a bit less pronounced than it looks. Also, notice that most of the points in this plot are below parity (i.e., below 1.0 on the y-axis), indicating that this codon position is relatively pyrimidine-rich.
The third (so-called "wobble") position of the codon shows considerable variation in values, but the slope of the curve is less than in the previous two graphs, and this position is pyrimidine-rich for about two-thirds of the organisms.
It's well known that GC-skew tends to be exaggerated in position 3 of the codon. For example, if the overall genome G+C is 70%, the position-wise G+C for the wobble base may be 90%. Surprisingly, we find that purine loading is most exaggerated in position 1 of the codon, not position 3. Not only is the slope of the purine-ratio curve shallower in position 3 than for the other two base positions, only position 1 is actually purine-heavy: positions 2 and 3 tend to be net pyrimidine-rich. This fact (that purine loading is primarily localized to codon position 1, whereas GC-skew is exaggerated in position 3) might indicate that the forces responsible for purine loading are entirely different from the forces responsible for GC skew.
What might those forces be? What kinds of selection pressure might cause organisms to purine-load one strand of their DNA? One possibility is that purine loading of the coding strand is a strategy for protecting the "weaker" or more vulnerable strand from damage or mutations. Cytosine is thought to be particularly vulnerable to deamination (and later substitution with thymine, during repair). It's possible that the transcription process (which is asymmetric, in that RNA polymerase operates against just one strand of DNA, leaving the other strand free) is protective of the antisense strand of DNA. That is, in transcription, RNA polymerase cloaks the antisense strand and in so doing renders that strand less vulnerable to deamination events, rogue methylations, etc., while transcription is taking place.
An entirely different possibility is envisioned by an RNA World hypothesis. In this hypothesis, the genetic material of early ancestor organisms was single-stranded RNA. Since single-stranded RNA is not "complementary" to anything, there is no need for it to obey Chargaff symmetries. Thus, purine loading could have occurred prior to the advent of double-stranded DNA, and early organisms could have been uniformly AT-rich. In this model of the world, GC-rich genomes are a late development, and the processes responsible for creating GC-rich DNA led to genetic material with full Chargaff base parity.
We may not know for a long time (if ever) what the mechanisms of purine enrichment are. But we know for sure that purine accumulation is a widespread phenomenon in the bacterial world (operating across diverse clades) and happens in a way that encourages purine-rich mRNA in organisms with low G+C content in their genomes.
Organisms used in this study:
It's easy to understand why the first parity rule holds true, because complementarity of DNA strands depends on A pairing with T and G pairing with C; these pairings give rise to the "rungs" of the DNA ladder and ensure that copying of strands occurs with total fidelity during cell division. But there doesn't seem to be any a priori reason why the second parity rule should hold true. And in fact, it often doesn't hold true, as Wacław Szybalski noted in 1966 when he reported finding imbalances of purines and pyrimidines in bacteriophage and other DNA samples. Szybalski observed that in most cases, protein-coding regions of DNA tend to have slightly more purines than pyrimidines on one strand and slightly more pyrimidines than purines on the other strand, such that messenger RNA ends up purine-heavy.
If you're having trouble visualizing the situation, imagine a very short (12-base) "chromosome" containing 50% G+C content. One possibility is that one strand looks like GGGGGGTTTTTT and the other strand is CCCCCCAAAAAA. In this case half the purines (all the G's) are on one strand and half (A's) are on the other. But you could just as easily have strands be GGGGGGAAAAAA and CCCCCCTTTTTT. In this case, one strand is all-purines, the other all-pyrimidines. Both examples violate Chargaff's second rule, which requires that G = C and A = T within each strand (e.g., GGGCCCTTTAAA + CCCGGGAAATTT would obey the rule).
To my knowledge, no one has yet reported the fact (which I'll now report) that the degree to which Chargaff's second parity rule is violated depends on the G+C content of the source genome (at least for bacteria). Simply put, organisms with a G+C content of around 68% obey Chargaff's rules. Organisms with more than 68% G+C content violate Chargaff's second rule in the direction of pyrimidine loading of mRNA. Organisms with less than 68% G+C content (which of course includes the overwhelming majority of organisms) have purine-heavy DNA, to a degree that depends on the amount of A+T in the DNA.
![]() |
| Purine/pyrimidine ratio (in coding regions) as a function of genome G+C content based on codon analysis of 93 organisms. As genomes become more A+T rich, mRNA becomes more heavily purine-loaded. |
The above graph shows how this relationship works. To create the graph, I did a statistical analysis of codon usage in 93 bacterial species. Organisms were chosen so as to obtain representatives across the AT/GC spectrum. No genus is represented more than once. In order to get as broad a sampling as possible, I included 14 intracellular symbionts with ultra-low G+C content (plus one such creature—Candidatus Hodgkinia cicadicola—with a 58% G+C content); many extremophiles; heterotrophs and autotrophs; pathogens and non-pathogens; and organisms with large and small genomes. The complete organism list is presented in a table further below.
Codon usage statistics for each organism were obtained using tools at http://genomevolution.org. Relative prevalences of A, T, G, and C in the genomes' coding regions were determined by codon frequency analysis. The purine:pyrimidine ratio was simply calculated as (A+G)/(C+T) based on the codon-wise frequency of usage of each base.
What we see is that while there is a good deal of noise in the data, nevertheless it's quite clear that purine/pyrimidine ratios increase sharply as genome G+C decreases.Organisms for which Chargaff's second rule holds true (points falling at y = 1.0) are in a small minority. Most organisms have purine-rich coding regions, resulting in purine-rich mRNA.
Purine enrichment occurs for both adenine and guanine. For example, in Clostridium botulinum (genome G+C = 28.21%), codon analysis reveals G/C/A/T relative abundances (on the coding strand) of 18.3/10.8/40.3/30.6.
Intra-codon base position analysis reveals that purine enrichment is far more concentrated in position one of the codon than other positions. The graphs below show the purine balance on a position-by-position basis, for each base in a codon.
Most of the variation in purine/pyrimidine ratio happens in position 1 of the codon (the 'A' in ATG, for example). Notice that the purine/pyrimidine ratio in this position is well above 1.0 for all organisms.
Variation in purine loading at the second position of the codon is more carefully controlled (notice that there is less "scatter" in this graph). The y-axis scale is different here than in the previous graph, hence the slope is quite a bit less pronounced than it looks. Also, notice that most of the points in this plot are below parity (i.e., below 1.0 on the y-axis), indicating that this codon position is relatively pyrimidine-rich.
The third (so-called "wobble") position of the codon shows considerable variation in values, but the slope of the curve is less than in the previous two graphs, and this position is pyrimidine-rich for about two-thirds of the organisms.
It's well known that GC-skew tends to be exaggerated in position 3 of the codon. For example, if the overall genome G+C is 70%, the position-wise G+C for the wobble base may be 90%. Surprisingly, we find that purine loading is most exaggerated in position 1 of the codon, not position 3. Not only is the slope of the purine-ratio curve shallower in position 3 than for the other two base positions, only position 1 is actually purine-heavy: positions 2 and 3 tend to be net pyrimidine-rich. This fact (that purine loading is primarily localized to codon position 1, whereas GC-skew is exaggerated in position 3) might indicate that the forces responsible for purine loading are entirely different from the forces responsible for GC skew.
What might those forces be? What kinds of selection pressure might cause organisms to purine-load one strand of their DNA? One possibility is that purine loading of the coding strand is a strategy for protecting the "weaker" or more vulnerable strand from damage or mutations. Cytosine is thought to be particularly vulnerable to deamination (and later substitution with thymine, during repair). It's possible that the transcription process (which is asymmetric, in that RNA polymerase operates against just one strand of DNA, leaving the other strand free) is protective of the antisense strand of DNA. That is, in transcription, RNA polymerase cloaks the antisense strand and in so doing renders that strand less vulnerable to deamination events, rogue methylations, etc., while transcription is taking place.
An entirely different possibility is envisioned by an RNA World hypothesis. In this hypothesis, the genetic material of early ancestor organisms was single-stranded RNA. Since single-stranded RNA is not "complementary" to anything, there is no need for it to obey Chargaff symmetries. Thus, purine loading could have occurred prior to the advent of double-stranded DNA, and early organisms could have been uniformly AT-rich. In this model of the world, GC-rich genomes are a late development, and the processes responsible for creating GC-rich DNA led to genetic material with full Chargaff base parity.
We may not know for a long time (if ever) what the mechanisms of purine enrichment are. But we know for sure that purine accumulation is a widespread phenomenon in the bacterial world (operating across diverse clades) and happens in a way that encourages purine-rich mRNA in organisms with low G+C content in their genomes.
Organisms used in this study:
| Organism | GC% | genome size |
| Anaeromyxobacter dehalogenans 2CP-1 | 74.67 | 5009007 |
| Cellulomonas flavigena strain DSM 20109 | 74.29 | 4123179 |
| Xylanimonas cellulosilytica strain DSM 15894 | 72.47 | 3831380 |
| Streptomyces bingchenggensis strain BCW-1 | 70.75 | 11936683 |
| Myxococcus fulvus strain HW-1 | 70.63 | 9003593 |
| Rubrobacter xylanophilus strain DSM 9941 | 70.48 | 3225748 |
| Rhodospirillum centenum ATCC 51521 | 70.46 | 4355543 |
| Actinomyces sp. oral taxon 175 strain F0384 | 68.73 | 3133330 |
| Rhodococcus equi strain ATCC 33707 | 68.72 | 5259057 |
| Acidovorax avenae subsp. citrulli strain AAC00-1 | 68.53 | 5352772 |
| Bordetella bronchiseptica strain RB50 | 68.08 | 5339179 |
| Alicycliphilus denitrificans strain K601 | 67.81 | 5070751 |
| Stenotrophomonas maltophilia strain JV3 | 66.89 | 4544477 |
| Rhodobacter capsulatus strain SB 1003 | 66.56 | 3871920 |
| Pseudomonas aeruginosa strain PA7 | 66.45 | 6588339 |
| Ralstonia eutropha strain H16 | 66.29 | 7416678 |
| Xanthomonas campestris pv. raphani strain 756C | 65.29 | 4941214 |
| Thioalkalivibrio sp. strain HL-EbGR7 | 65.06 | 3470516 |
| Rhodopseudomonas palustris strain BisB18 | 64.96 | 5513844 |
| Brevundimonas diminuta strain ATCC 11568 | 64.51 | 3369316 |
| Rhodothermus marinus strain DSM 4252 | 64.09 | 3386737 |
| Bradyrhizobium japonicum strain USDA 110 | 64.06 | 9105828 |
| Mycobacterium tuberculosis strain C | 63.82 | 4379118 |
| Thermanaerovibrio acidaminovorans strain DSM 6589 | 63.79 | 1848474 |
| Halomonas elongata DSM 2581 strain type DSM 2581 | 63.61 | 4061296 |
| Novosphingobium nitrogenifigens strain DSM 19370 | 63.43 | 4182647 |
| Polaromonas sp. strain JS666 | 62.24 | 5898676 |
| Desulfovibrio africanus strain Walvis Bay | 61.42 | 4200534 |
| Candidatus Desulforudis audaxviator strain MP104C | 60.85 | 2349476 |
| Burkholderia rhizoxinica strain HKI 454 | 60.68 | 3750138 |
| Slackia heliotrinireducens strain DSM 20476 | 60.21 | 3165038 |
| Candidatus Nitrospira defluvii | 59.03 | 4317083 |
| Halogeometricum borinquense DSM 11551 | 58.43 | 3944467 |
| Candidatus Hodgkinia cicadicola strain Dsem | 58.39 | 143795 |
| Sideroxydans lithotrophicus strain ES-1 | 57.54 | 3003656 |
| Cenarchaeum symbiosum A | 57.37 | 2045086 |
| Serratia sp. strain AS12 | 55.96 | 5443009 |
| Acidaminococcus fermentans strain DSM 20731 | 55.84 | 2329769 |
| Hyperthermus butylicus strain DSM 5456 | 53.74 | 1667163 |
| Methanosaeta thermophila (Methanothrix thermophila PT) strain PT | 53.55 | 1879471 |
| Neisseria gonorrhoeae strain NCCP11945 | 53.37 | 2236178 |
| Treponema paraluiscuniculi strain Cuniculi A | 52.74 | 1133390 |
| Pseudovibrio sp. strain FO-BEG1 | 52.38 | 5916782 |
| Nitrosococcus halophilus strain Nc4 | 51.60 | 4145260 |
| Herpetosiphon aurantiacus DSM 785 | 50.84 | 6785430 |
| Escherichia coli B strain REL606 | 50.77 | 4629812 |
|
50.65 | 3782950 |
| Pectobacterium wasabiae strain WPP163 | 50.48 | 5063892 |
| Anaplasma centrale (Anaplasma marginale subsp. centrale str. Israel) strain Israel | 49.98 | 1206806 |
| Actinomyces coleocanis strain DSM 15436 | 49.47 | 1723843 |
| Desulfotalea psychrophila strain LSv54 | 46.72 | 3659634 |
| Polynucleobacter necessarius strain STIR1 | 45.56 | 1560469 |
| Nitrosomonas sp. strain Is79A3 | 45.44 | 3783444 |
| Coprothermobacter proteolyticus strain DSM 5265 | 44.77 | 1424912 |
| Vibrio sp. Ex25 strain EX25 | 44.57 | 5160431 |
| Geobacillus thermoglucosidans strain TNO-09.020 | 43.82 | 3740238 |
| Waddlia chondrophila strain 2032/99 | 43.59 | 2139757 |
| Bacteroides fragilis strain 638R | 43.42 | 5373121 |
| Thiomicrospira crunogena strain XCL-2 | 43.13 | 2427734 |
| Coxiella burnetii strain CbuG_Q212 | 42.63 | 2008870 |
| Chlamydia muridarum Nigg strain MoPn | 40.27 | 1080451 |
| Psychromonas ingrahamii strain 37 | 40.09 | 4559598 |
| Nitratiruptor sp. strain SB155-2 | 39.69 | 1877931 |
| Lactobacillus reuteri strain DSM 20016 | 38.87 | 1999618 |
| Thermotoga lettingae strain TM | 38.70 | 2135342 |
| Streptococcus pyogenes strain Alab49 | 38.63 | 1841271 |
| Bartonella bacilliformis strain ATCC 35685; KC583 | 38.24 | 1445021 |
| Halothermothrix orenii strain DSM 9562; H 168 | 37.78 | 2463968 |
| Staphylothermus marinus strain F1 | 35.73 | 1570485 |
| Calditerrivibrio nitroreducens strain DSM 19672 | 35.69 | 2216552 |
| Bacillus thuringiensis serovar andalousiensis strain BGSC 4AW1 | 34.96 | 5488844 |
| Desulfurobacterium thermolithotrophum | 34.95 | 1541968 |
| Wolbachia pipientis strain wPip | 34.19 | 1482455 |
| Nitrosopumilus maritimus strain SCM1 | 34.17 | 1645259 |
| Staphylococcus aureus strain 04-02981 | 32.90 | 2821452 |
| Methanobrevibacter ruminantium strain M1 | 32.64 | 2937203 |
| Rickettsia japonica strain YH | 32.35 | 1283087 |
| Methanocaldococcus fervens strain AG86 (v1) | 32.21 | 1507251 |
| Mycoplasma genitalium G37 strain G-37 | 31.69 | 580076 |
| Nanoarchaeum equitans strain Kin4-M | 31.56 | 490885 |
| Orientia tsutsugamushi strain Boryong | 30.53 | 2127051 |
| Methanococcus aeolicus strain Nankai-3 | 30.04 | 1569500 |
| Candidatus Pelagibacter ubique strain HTCC1062 | 29.68 | 1308759 |
| Ehrlichia canis strain Jake | 28.96 | 1315030 |
| Arcobacter nitrofigilis strain DSM 7299 | 28.36 | 3192235 |
| Clostridium botulinum A strain ATCC 19397 | 28.21 | 3863450 |
| Parvimonas sp. oral taxon 393 strain F0440 | 28.17 | 1483165 |
| Candidatus Arthromitus sp. strain SFB-mouse-NYU | 27.94 | 1569870 |
| Candidatus Blochmannia floridanus | 27.38 | 705557 |
| Buchnera aphidicola (Acyrthosiphon pisum) strain 5A | 25.69 | 653223 |
| Wigglesworthia glossinidia endosymbiont of Glossina brevipalpis | 22.48 | 703004 |
| Candidatus Sulcia muelleri strain CARI (v1) | 21.13 | 276511 |
| Candidatus Carsonella ruddii strain PV (v1) | 16.56 | 159662 |
Subscribe to:
Posts (Atom)






